European Journal of Clinical Pharmacology

, Volume 69, Issue 3, pp 727–728 | Cite as

Interaction between ciclopirox and acenocoumarol

  • José A. Morales-Molina
  • Rosario Pérez-Moyano
  • Anna Fayet-Pérez
  • Olivia Urquízar-Rodríguez
  • M. José Gíménez-López
Letter to the Editors
First Online:
Received:
Accepted:

Keywords

Omeprazole International Normalize Ratio Carvedilol Fluvastatin Bisoprolol 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Notes

Conflicts of interest

None.

References

  1. 1.
    Subissi A, Monti D, Togni G, Mailland F (2012) Ciclopirox: recent nonclinical and clinical data relevant to its use as a topical antimycotic agent. Drugs 70:2133–2152. doi: 10.2165/11538110-000000000-00000 CrossRefGoogle Scholar
  2. 2.
    Ciclopirox (2012) DRUGDEX System. Greenwood Village, CO: Thomson Micromedex Healthcare Series expires 31/12/2012 (accessed 24/06/2012)Google Scholar
  3. 3.
    Morales-Molina JA, Fayet-Pérez A, Martínez-Plata E, Pérez-Moyano R, Molina-Arrebola MA (2012) Interaction between amorolfine and acenocoumarol. Eur J Clin Pharmacol. doi: 10.1007/s00228-012-1305-7
  4. 4.
    Traynor MJ, Turner RB, Evans CR, Khengar RH, Jones SA, Brown MB (2010) Effect of a novel penetration enhancer on the ungual permeation of two antifungal agents. J Pharm Pharmacol 62:730–737. doi: 10.1211/jpp/62.06.0009 PubMedGoogle Scholar
  5. 5.
    Bohn M, Kraemer KT (2000) Dermatopharmacology of ciclopirox nail lacquer topical solution 8 % in the treatment of onychomycosis. J Am Acad Dermatol 43:S57–S69. doi: 10.1067/mjd.2000.109072 PubMedCrossRefGoogle Scholar
  6. 6.
    Ciclopirox U.S (2004) Food and Drug Administration. Silver Spring, MD. http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21022s004lbl.pdf
  7. 7.
    Horn JR, Hansten PD, Chan L-N (2007) Proposal for a new tool to evaluate drug interaction cases. Ann Pharmacother 41:674–680. doi: 10.1345/aph.1H423 PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • José A. Morales-Molina
    • 1
  • Rosario Pérez-Moyano
    • 2
  • Anna Fayet-Pérez
    • 1
  • Olivia Urquízar-Rodríguez
    • 1
  • M. José Gíménez-López
    • 2
  1. 1.Pharmacy DepartmentHospital de PonienteEl EjidoSpain
  2. 2.Hematology DepartmentHospital de PonienteEl EjidoSpain

Personalised recommendations